INSCI STATEMENTS COM CORP
SC 13D, 2000-02-28
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: NUVEEN FLORIDA QUALITY INCOME MUNICIPAL FUND INC, NSAR-A, 2000-02-28
Next: EMBREX INC/NC, SC 13G/A, 2000-02-28



<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13D

                    Under The Securities Exchange Act Of 1934
                               (Amendment No. 1 )

                           insci-statements.com, corp.
         ---------------------------------------------------------------
                                (Name of Issuer)

                      Common Stock $/01 par value per share
         ---------------------------------------------------------------
                         (Title of Class of Securities)

                                    45765T106
                  --------------------------------------------
                                 (CUSIP Number)

                                Joseph A. Baratta
                               Baratta & Goldstein
                                597 Fifth Avenue
                               New York, NY 10017
                                  212-750-9700
                  --------------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)


                  --------------------------------------------
           (Date of Event which Requires the Filing of this Statement)

                                       * *


If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>

CUSIP No. 45765T106                                      13D

1.  NAME OF REPORTING PERSON
    S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    Dr. E Ted Prince
    ---------------------------------------------------------------------------

2.  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    ------------------------------------------------------------ (a)  [   ]

    ------------------------------------------------------------ (b)  [   ]

3.  SEC USE ONLY

    -----------------------------------------------------------------------

4.  SOURCE OF FUNDS (See Instructions)
                        OO
    -----------------------------------------------------------------------

5.  CHECK IF DISCLOSURE LO LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
    ITEMS 2(d) or 2(e) [   ]

   ------------------------------------------------------------------------

6.  CITIZENSHIP OR PLACE OF ORGANIZATION

                  U.S.A
   ------------------------------------------------------------------------

       NUMBER OF           7.       SOLE VOTING POWER
        SHARES                         1,456,787
     BENEFICIALLY                   -------------------------------
       OWNED BY            8.       SHARED VOTING POWER
         EACH                             0
       REPORTING                    -------------------------------
        PERSON             9.       SOLE DISPOSITIVE POWER
         WITH                          1,456,787
                                    -------------------------------
                           10.      SHARED DISPOSITIVE POWER
                                          0
                                    -------------------------------

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                       1,456,787
    ----------------------------------------------------------------------------

12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [   ]

    ----------------------------------------------------------------------------

13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

                      12.4%
    ----------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON*

    IN
    ----------------------------------------------------------------------------
                                  SCHEDULE 13D
<PAGE>
ITEM 1.      SECURITY AND ISSUER.

             This Schedule is filed with respect to the Common Stock , $.01 par
             value (the "Common Stock") of the issuer, insci-statements.com,
             corp., formerly known as Insci Corp. ("insci"). insci's principal
             executive offices are located at Two Westborough Business Park,
             Westborough, Massachusetts 01581.

ITEM 2.      IDENTITY AND BACKGROUND.

        (a)  This Schedule 13D is filed on behalf of Dr. E. Ted Prince (the
             "Reporting Person").

        (b)  The Reporting Person's principal business address at Two
             Westborough Business Park, Westborough, Massachusetts 01581.

        (c)  The present principal occupation of the Reporting person Chairman
             of the Board of Directors and Chief Executive Officer of insci. The
             address of insci is at Two Westborough Business Park, Westborough,
             Massachusetts 01581.

        (d)  During the last five years, the Reporting Person has not been
             convicted in a criminal proceeding (excluding traffic violations or
             similar misdemeanors).

        (e)  During the last five years, the Reporting Person has not been a
             party to a civil proceeding of a judicial or administrative body of
             competent jurisdiction that resulted in a judgment, decree or final
             order enjoining future violations of, or prohibiting or mandating
             activities subject to, federal or state securities laws or finding
             any violation with respect to such laws.

        (f)  The Reporting Person is a citizen of the United States.

ITEM 3.      SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

             The reporting person has previously reported beneficial ownership
             of 1,248,180 shares of Common Stock on Schedule 13D. Subsequently,
             the Reporting Person has acquired and or has become vested in an
             additional 325,000 options pursuant to his employment contract with
             the Issuer . Additionally, the Reporting Person had previously
             purchased nominal amounts of Common Stock (11,000 shares) with
             personal funds and converted shares of 10% Convertible Preferred
             Stock and received dividends, both in the form of Common Stock
             (26,787 shares).

ITEM 4.      PURPOSE OF TRANSACTION.

        (a)  The shares of Common Stock reported in this Schedule are held for
             investment purposes. Depending upon trading prices of Common Stock
             and upon the Reporting Person's personal financial position and
             goals from time to time, the Reporting Person may, subject to
             applicable statutory and other limitations, purchase additional
             shares of Common Stock or dispose of Common Stock in the open
             market, in privately negotiated transactions, or otherwise. The
             Reporting Person retains the right to evaluate his position in the
             future and change his intent with respect to any future actions.

             Other than as described above, the Reporting Person has no plans or
             proposals which relate to, or may result in, any of the matters
             listed in Item 4 (a) through (I) of Schedule 13D (although he
             reserves the right to develop such plans).

             (b), (c), (d), (e), (f), (g), (h), (i) and (j): Not Applicable.

ITEM 5:      INTEREST IN SECURITIES OF THE ISUER.

        (a)  After giving effect to the transaction described in Item 3, the
             aggregate number of shares of Common Stock beneficially owned by
             the Reporting Person is 1,456,787 or approximately 12.4% of the
             issued and outstanding shares of Common Stock. The shares
             beneficially owned by the Reporting Person include 1,434,000 shares
             of Common Stock which may be acquired pursuant to options to
             purchase Common Stock owned by the Reporting Person.

        (b)  The number of shares of Common Stock as to which the Reporting
             Person has the sole power to vote, direct the vote, to dispose and
             to direct the disposition is 1,456,787 shares, and the number of
             shares of Common Stock as to which the Reporting Person shares the
             power to vote, to direct the vote, to dispose and to direct the
             disposition is 0.

        (c)  Within the last 60 days, the Reporting Person exercised and sold
             50,000 stock options on or about February 7, 2000, 50,000 stock
             options on or about February 11, 2000 and 16,000 stock options on
             or about February 14, 2000.

        (d)  Not applicable.

        (e)  Not applicable.


ITEM 6.      CONTRACTS, ARRANGEMENTS, UNDERTAKINGS OR RELATIONSHIPS WITH RESPECT
             TO SECURITES OF THE ISSUER.

             There are no contracts, arrangements, undertakings or relationships
             (legal or otherwise) between the Reporting Person and any person
             with respect to the securities of the Issuer.

ITEM 7.      MATERIALS TO BE FILED AS EXHIBITS.

             Not applicable

                                    SIGNATURE

             After reasonable inquiry and to the best of my knowledge and
             belief, I certify that the information set forth in this statement
             is true, complete and correct.


                                                               February 25, 2000
                                                               -----------------
                                                                      Date

                                                          /s/ Dr. E. Ted Prince
                                                          ----------------------
                                                              Dr. E. Ted Prince



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission